FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4581211000001107: Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17951301000001112 Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52373101000001114 Sodium nitroprusside 50mg powder for solution for infusion vials (Hospira UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Is a Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has active ingredient Nitroprusside false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has active ingredient Sodium nitroprusside false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has active ingredient Sodium nitroprusside dihydrate false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has specific active ingredient Sodium nitroprusside dihydrate false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has specific active ingredient Sodium nitroprusside dihydrate true Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) 5 vial Is pack of False Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) 5 vial Has AMP True Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start